LACK OF ACIPIMOX DIGOXIN INTERACTION IN PATIENT VOLUNTEERS

被引:0
|
作者
CHIJIOKE, CP [1 ]
PEARSON, RM [1 ]
BENEDETTI, S [1 ]
机构
[1] ST BARTHOLOMEWS HOSP, DEPT CLIN PHARMACOL, LONDON EC1A 7BE, ENGLAND
关键词
D O I
10.1177/096032719201100509
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
1 A study was carried out to find out if digoxin and acipimox interact. 2 Six elderly patients on digoxin were each given acipimox 150 mg three daily for a week, after informed consent. Digoxin and acipimox plasma concentrations and urinary excretion were measured after the first dose of acipimox and after a week of treatment 3 Data were fitted to a one-compartment oral absorption model. Areas under the plasma concentration-time curve, plasma and renal clearances, and elimination half-life were computed. 4 There was no significant difference in digoxin plasma concentrations and kinetic parameters before and after acipimox administration. Acipimox kinetics were not affected by the concomitant ingestion of digoxin. 5 The patients' clinical condition remained stable during the study. 6 Thus there was no evidence for an adverse interaction between digoxin and acipimox in human subjects under the conditions of this study.
引用
收藏
页码:357 / 359
页数:3
相关论文
共 50 条
  • [41] Lack of pharmacokinetic interaction between vildagliptin and amlodipine in healthy volunteers
    He, YL
    Zhao, CX
    Wang, Y
    Campestrini, J
    Prasad, P
    Marion, A
    Ligueros-Saylan, M
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1084 - 1084
  • [42] LACK OF INTERACTION OF TIAPROFENIC ACID WITH WARFARIN IN HEALTHY-VOLUNTEERS
    JONES, RW
    WARD, GT
    FREEMAN, M
    DRYSDALE, HC
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1986, 59 : 195 - 195
  • [43] Lack of pharmacokinetic interaction between vildagliptin and ramipril in healthy volunteers
    He, Y. L.
    Sabo, R.
    Wang, Y.
    Campestrini, J.
    Ligueros-Saylan, M.
    Dole, W. P.
    Howard, D.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (09): : 1082 - 1082
  • [44] Lack of Clinically Relevant Drug-Drug Interaction Between Empagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, and Verapamil, Ramipril, or Digoxin in Healthy Volunteers
    Macha, Sreeraj
    Sennewald, Regina
    Rose, Peter
    Schoene, Katja
    Pinnetti, Sabine
    Woerle, Hans J.
    Broedl, Uli C.
    CLINICAL THERAPEUTICS, 2013, 35 (03) : 226 - 235
  • [45] LACK OF A PHARMACOKINETIC INTERACTION BETWEEN DIMEBON (LATREPIRDINE) AND DIGOXIN IN HEALTHY SUBJECTS.
    Qiu, R.
    Plowchalk, D.
    Byon, W.
    Terra, S.
    Corrigan, B.
    Mordenti, J.
    Fang, J.
    Fullerton, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S91 - S91
  • [46] Lack of interaction between valaciclovir, the L-valyl ester of aciclovir, and digoxin
    Soul-Lawton, JH
    Weatherley, BC
    Posner, J
    Layton, G
    Peck, RW
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (01) : 87 - 89
  • [47] FURTHER INSIGHTS INTO DIGOXIN-QUINIDINE INTERACTION - LACK OF CORRELATION BETWEEN SERUM DIGOXIN CONCENTRATION AND INOTROPIC STATE OF THE HEART
    HIRSH, PD
    WEINER, HJ
    NORTH, RL
    AMERICAN JOURNAL OF CARDIOLOGY, 1980, 46 (05): : 863 - 868
  • [48] Absence of a pharmacokinetic interaction of rilpivirine with the P-glycoprotein substrate digoxin in healthy volunteers
    Crauwels, H.
    Deckx, H.
    Enweonye, I
    Stevens, M.
    Hoetelmans, R.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 58 - 59
  • [49] Evaluation of the pharmacokinetic interaction after multiple oral doses of linagliptin and digoxin in healthy volunteers
    C. Friedrich
    A. Ring
    T. Brand
    R. Sennewald
    E. U. Graefe-Mody
    H.-J. Woerle
    European Journal of Drug Metabolism and Pharmacokinetics, 2011, 36 : 17 - 24
  • [50] Evaluation of the pharmacokinetic interaction after multiple oral doses of linagliptin and digoxin in healthy volunteers
    Friedrich, C.
    Ring, A.
    Brand, T.
    Sennewald, R.
    Graefe-Mody, E. U.
    Woerle, H. -J.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2011, 36 (01) : 17 - 24